Skip to main content

Label updates for some Flea and Tick Products

September 28, 2018 | Posted by: Dr. Renee Forcier DVM


Did you hear?

The Food and Drug Administration (FDA) recently sent out a statement regarding certain flea and tick medications. What does this mean for you and your pet? We are here for you to answer any questions that you may have!

The statement issued by the FDA is regarding updated labeling information for some flea and tick preventative medications including Bravecto, Credelio, Nexgard, and Simparica. There have been no changes to these medications, and all of those listed are approved to be safe and effective for protecting your pet against flea and tick infestations. This type of monitoring and updating for medications is normal for all drugs approved by the FDA.

What does this mean?

The labels are being updated to notify of a small risk of neurological events (tremors, ataxia, and seizures) which were rarely seen during safety studies using high doses of medication for several months. The most common side effects of these medications include vomiting, diarrhea, and lethargy. Less than 1 in 10,000 animals may be affected with these side effects. Neurological side effects are even more rare! This information is already on the label for Simparica, so there will be no changes for that product.

If you have further questions or concerns regarding the FDA statement on labels for Bravecto, Credelio, Nexgard, or Simparica, please feel free to contact us! We are here for you and your pet!





Dr. Forcier attended Barry University in Miami Shores, Florida, where she completed her undergraduate education in Biology with a minor in Chemistry. She then moved on to veterinary school at Atlantic Veterinary College. Her special interest are in exotic animal medicine, surgery, ophthalmology, and nutrition.


comments powered by Disqus